ANA vs ENA — Autoantibody Testing
Screen first with ANA; refine the diagnosis with ENA. Clear / Transparent Glass presentation.
ANA is a broad screening test that detects autoantibodies against the nucleus, and it is used to screen for a range of autoimmune diseases. A positive ANA test is common in diseases like SLE, Sjögren’s syndrome, and scleroderma.
ENA is a more specific follow-up test to detect specific autoantibodies associated with particular autoimmune diseases. For example, Ro/SSA and La/SSB are associated with Sjögren’s syndrome, while Sm is highly specific for SLE.
ANA (Antinuclear Antibody)
Definition
ANA refers to autoantibodies that target various components of the nucleus of cells, including DNA, histones, ribosomes, nucleoproteins, and other nuclear antigens.
ANA is a screening test for autoimmune diseases and is often one of the first tests ordered when an autoimmune condition is suspected.
Function
ANA antibodies bind to the nuclear material in cells, which can cause inflammation, tissue damage, and immune system dysfunction in various tissues, particularly in the skin, joints, and kidneys.
Clinical Significance
Positive ANA results are associated with various autoimmune diseases, particularly:
- Systemic Lupus Erythematosus (SLE)
- Sjögren’s Syndrome
- Rheumatoid Arthritis (RA)
- Scleroderma
- Mixed Connective Tissue Disease (MCTD)
- Polymyositis/Dermatomyositis
- Hashimoto’s Thyroiditis
ANA Testing
- Measured via indirect immunofluorescence (IIF) or ELISA.
- Results may be positive or negative; a positive test does not diagnose a specific disease.
- Titer & Pattern (e.g., speckled, homogeneous, nucleolar) add diagnostic clues.
Normal Range
- Negative ANA: No antinuclear antibodies detected.
- Positive ANA: Titer/pattern vary; higher titers often correlate with active disease.
ENA (Extractable Nuclear Antigen)
Definition
ENA refers to a group of autoantigens found in the nucleus that can be extracted in the laboratory. The ENA panel detects antibodies against specific proteins such as Ro/SSA, La/SSB, Sm, RNP, Jo-1, and others.
Unlike ANA, which is broad, ENA focuses on specific autoantibodies linked to particular autoimmune conditions.
Function
ENA antibodies are more specific than ANA and can refine the diagnostic picture—especially for Sjögren’s syndrome, SLE, and dermatomyositis.
Clinical Significance
- Ro/SSA & La/SSB: Sjögren’s syndrome, SLE, neonatal lupus.
- Sm: Highly specific for SLE.
- RNP: Mixed Connective Tissue Disease (MCTD).
- Jo-1: Dermatomyositis/polymyositis; anti-synthetase syndrome.
Normal Range
- Negative ENA: No extractable nuclear antibodies detected.
- Positive ENA: Specificities help differentiate autoimmune disorders.
Putting It Together
ANA is useful as an initial screen, while ENA testing helps narrow the diagnosis and identify which specific autoimmune disorder is present—always interpreted in clinical context.
Further reading (PDF): ANA · ANA vs ENA · Corticosteroids & ANA